Stay updated on Efficacy of OBE2109 in Uterine Fibroids Clinical Trial
Sign up to get notified when there's something new on the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page.

Latest updates to the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, and the revision status shows as v3.3.2. The previous wording describing PubMed publications as automatically created by ClinicalTrials.gov and tied to the NCT number has been removed.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the banner notice about government funding impacting site updates and the NIH Clinical Center's operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedCore study information remains unchanged; the screenshots show only minor UI/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded a new literature citation about linzagolix (PRIMROSE 1 & 2) with details; no deletions were made.SummaryDifference1%

- Check62 days agoChange DetectedThe page now displays an updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check69 days agoChange DetectedUpdate: version tag changed from v3.0.2 to v3.1.0, indicating a newer release update.SummaryDifference0.1%

Stay in the know with updates to Efficacy of OBE2109 in Uterine Fibroids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page.